Association of 22 cytokine gene polymorphisms with tuberculosis in Macedonians

Indian Journal of Tuberculosis

Volumn 56, Issue 3, 2009, Pages 117-131

  Trajkov, Dejan ^a   Trajchevska, Mirjana ^b   Arsov, Todor ^a   Petlichkovski, Aleksandar ^a   Strezova, Ana ^a   Efinska Mladenovska, Olivija ^a   Sandevski, Aleksandar ^a   Spiroski, Mirko ^a  

^a SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^b Inst for Lung Dis and Tuberculosis   (Macedonia)

Author keywords

Cytokine polymorphism; Macedonians; TB

Indexed keywords

ALPHA INTERFERON; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HOST RESISTANCE; HOST SUSCEPTIBILITY; HUMAN; LUNG TUBERCULOSIS; MACEDONIA (REPUBLIC); MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREECE; HAPLOTYPES; HUMANS; INTERLEUKIN-2; INTERLEUKINS; MIDDLE AGED; POLYMORPHISM, GENETIC; TUBERCULOSIS;

EID: 70349379428     PISSN: 00195707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (94)

1. Nunn P. The global control of tuberculosis: what are the prospects?. Scand J Infect Dis 2001;33:329-32.
2. Fatkenheuer G, Taelman H, Lepage P, Schwenk A, Wenzel R. The return of tuberculosis. Diagn Microbiol Infect Dis 1999;34:139-46.
3. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis and mortality during 1990-2000. Bull World Health Organ 1994;72: 213-220.
4. World Health Organization. The World Health Report 2004 - changing history, 2004.
5. Schluger NW. Recent advances in our understanding of human host responses to tuberculosis. Respir Res 2001;2:157-63.
6. Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 1978;117:621-4.
7. Fine PE. Immunogenetics of susceptibility to leprosy, tuberculosis and leishmaniasis. An epidemiological perspective. Int J Lepr Other Mycobact Dis 1981;49: 437-54.
8. Bellamy R. Genetic susceptibility to tuberculosis. Clin Chest Med 2005;26(2): 233-46.
9. Kallmann FJ, Reisner D. Twin studies on the significance of genetic factors in tuberculosis. Am Rev Tuberc 1942;47: 549-574.
10. Hoal EG. Human genetic susceptibility to tuberculosis and other mycobacterial diseases. IUBMB Life 2002;53(4-5): 225-9.
11. Malik S, Schurr E. Genetic susceptibility to tuberculosis. Clin Chem Lab Med 2002;40(9): 863-8.
12. Hill AV. The immunogenetics of human infectious diseases. Annu Rev Immunol 1998;16: 593-617.
13. Fenton MJ, Vermeulen MW. Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect Immun 1996;64: 683-690.
14. Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992;10:385-409.
15. Wallis RS, Ellner JJ. Cytokines and tuberculosis. J Leukoc Biol 1994;55:676-81.
16. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV. In vitro production of IFN-ã correlates with CA repeat polymorphism in the human IFN-ã gene. Eur J Immunogenet 1999; 28:1-3.
17. Kilpinen S, Huhtala H, Hurme M. The combination of the interleukin-1alpha (IL-1alpha-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals. Eur Cytokine Netw 2002;13(1):66-71.
18. Warle MC, Farhan A, Metselaar HJ, Hop WC, Perrey C, Zondervan PE, Kap M, Kwekkeboom J, Ijzermans JN, Tilanus HW, Pravica V, Hutchinson IV, Bouma GJ. Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl 2003;9(2):170-81.
19. Trajkov D, Arsov T, Petlichkovski A, Strezova A, EfinskaMladenovska O, Spiroski M. Cytokine gene polymorphisms in population of ethnic Macedonians. Croat Med J 2005;46(4):685-92.
20. World Health Organization. Treatment of tuberculosis. Guidelines for national programmes. 2nd ed, 1997. WHO/TB/97.220. Geneva: WHO, 1997.
21. Towner P. Purification of DNA. Essential Molecular Biology (ed.T.A.Brown). Oxford University Press, Oxford. 1995:47-54.
22. Spiroski M, Arsov T, Petlichkovski A, Strezova A, Trajkov D, Efinska-Mladenovska O, Zaharieva E. Case Study: Macedonian Human DNA Bank (hDNAMKD) as a source for public health Genetics. In: Health Determinants in the Scope of New Public Health. Ed. by Georgieva L, Burazeri G. Hans Jacobs Company: Sofia, 2005:33-44.
23. Tseng LH, Chen PJ, Lin MT, Singleton K, Martin EG, Yen AH, Martin PJ, Hansen JA. Simultaneous genotyping of single nucleotide polymorphisms in the IL-1 gene complex by multiplex polymerase chain reaction-restriction fragment length polymorphism. J Immunol Methods 2002;267: 151-6.
24. Helmberg W, Lanzer G, Zahn R, Weinmayr B, Wagner T, Albert E. Virtual DNA analysis - a new tool for combination and standardised evaluation of SSO, SSP and sequencingbased typing results. Tissue Antigens1998; 51:587-92.
25. Lancaster A, Nelson MP, Meyer D, Thomson G, Single RM. PyPop: a software framework for population genomics: analyzing large-scale multi-locus genotype data. Pac Symp Biocomput 2003;:514-25.
26. Lancaster AK, Single RM, Solberg OD, Nelson MP, Thomson G. PyPop update - a software pipeline for largescale multilocus population genomics. Tissue Antigens 2007;69(Suppl 1):192-7.
27. Single RM, Meyer D, Mack SJ, Lancaster A, Erlich HA, Thomson G. 14th International HLA and Immunogenetics Workshop: report of progress in methodology, data collection, and analyses. Tissue Antigens 2007;69(Suppl 1):185-7.
28. Guo S, Thomson E. Performing the exact test of Hardy Weinberg proportion for multiple alleles. Biometrics 1992;48:361.
29. Schneider S, Roessli D, Excoffier L. Arlequin version 2.000: a software for population genetics data analysis. Geneva (Switzerland): Genetics and Biometry Laboratory, University of Geneva; 2000.
30. Fenton MJ, Vermeulen MW. Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect Immun 1996;64: 683-690.
31. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;77: 1627-1652.
32. Nicklin MJH, Weith A, Duff GW. A physical map of the region encompassing the human inteleukin-1a, interleukin-1, and interleukin-1 receptor antagonist genes. Genomics 1994;19: 382-384.
33. Nicklin MJ, Barton JL, Nguyen M, FitzGerald MG, Duff GW, Kornman K. A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomes 2002;79: 718-725.
34. Sica A, Wang JM, Colotta F, Dejana E, Mantovani A, Oppenheim JJ, Larsen CG, Zachariae CD, Matsushima K. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol 1990;144(8): 3034-3038.
35. Hunter CA, Chizzonite R, Remington JS. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens. J Immunol 1995;155: 4347-4354.
36. Tsao TCY, Hong J, Li LF, Hsieh MJ, Liao SK, Chang KSS. Imbalances between tumor necrosis factor-Ü and its soluble receptor forms, and interleukin-1 and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis. Chest 2000;117: 103-109.
37. Marshall BG, Wangoo A, Cook HT, Shaw RJ. Increased inflammatory cytokines and new collagen formation in cutaneous tuberculosis and sarcoidosis. Thorax 1996; 51:1253-1261.
38. Bergeron A, Bonay M, Kambouchner M, Lecossier D, Riquet M, Soler P, Hance A, Tazi A. Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. J Immunol 1997;159: 3034-3043.
39. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998;16: 27-55.
40. Amirzargar AA, Rezaei N, Jabbari H, Danesh AA, Khosravi F, Hajabdolbaghi M, Yalda A, Nikbin B. Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. Eur Cytokine Netw 2006;17(2):84-9.
41. Gomez LM, Camargo, JF, Castiblanco J, Ruiz-Narvaez EA, Cadena J, Anaya JM. Analysis of IL1B, TAP1, TAP2 and IKBL polymorphisms on susceptibility to tuberculosis. Tissue Antigens 2006;67(4): 290-6.
42. Delgado JC, Baena A, Thim S, Goldfeld AE. Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis 2002; 186: 1463-1468.
43. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuberi Lung Dis 1998;79: 83-89.
44. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002;20: 581-620.
45. Schluger NW, Rom WN. The host immune response to tuberculosis. Am J Respir Crit Care Med 1998;157: 679-91.
46. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, Gorman D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW, Rennick D, deWaal-Malefyt R, Hannum C, Bazan JF, Kastelein RA. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000;13: 715-25.
47. Ma X, Reich RA, Gonzalez O, Pan X, Fothergill AK, Starke JR, Teeter LD, Musser JM, Graviss EA. No evidence for association between polymorphism in the 3′untranslated region of interleukin-12B and human susceptibility to tuberculosis. J Infect Dis 2003;188: 1116-8.
48. Puzyrev VP, Freidin MB, Rudko AA, Strelis AK, Kolokolova OV. Polymorphisms of tuberculosis susceptibility candidate genes in the Slavonic population of Siberia: A pilot study. Mol Biol 2002; 36 (5): 634-636.
49. Tso HW, Lau YL, Tam CM, Wong HS, Chiang AKS. Associations between IL12B polymorphisms and tuberculosis in the Hong Kong Chinese population. J Infect Dis 2004;190: 913-9.
50. Sahiratmadja E, Baak-Pablo R, de Visser AW, Alisjahbana B, Adnan I, van Crevel R, Marzuki S, van Dissel JT, Ottenhoff THM, van de Vosse E. Association of polymorphisms in IL-12/IFN-ã pathway genes with susceptibility to pulmonary tuberculosis in Indonesia. Tuberculosis 2007;87: 303-311.
51. Condos R, Rom W N, Liu Y M, Schluger N W. Local immune responses correlate with presentation and outcome in tuberculosis. Am J Respir Crit Care Med 1998;157: 729-735.
52. Dorman SE, Holland SM. Interferon-g and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000; 11:321-33.
53. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Huychinson IV. In vitro production of IFN-g correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1999;26(1):1-3.
54. Lopez-Maderuelo D, Arnalich F, Serantes R, Gonzales A, Codoceo R, Madero R, Vazquez JJ, Montiel C. Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 2003;167(7): 970-5.
55. Henao MI, Montes C, Paris SC, Garcia LF. Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis. Tuberculosis 2006;86: 11-19.
56. Lio D, Marino V, Serauto A, Gioia V, Scola L, Crivello A, Forte GI, Coloona-Romano G, Candore G, Caruso C. Genotype frequencies of the +874T→A single nucleotide polymorphism in the first intron of the interferon-gamma gene in a sample of Sicilian patients affected by tuberculosis. Eur J Immunogenet 2002;29(5): 371-4.
57. Rossouw M, Nel HJ, Cooke GS, van Helden PD, Hoal EG. Association between tuberculosis and a polymorphic NFKB binding site in the interferon ã gene. Lancet 2003;361: 1871-72.
58. Etokebe GE, Bulat-Kardum L, Johansen MS, Knezevic J, Balen S, Matakovic-Mileusnic N, Matanic D, Flego V, Pavelic J, Beg-Zec Z, Dembic Z. Interferon-ã gene (T874A and G2109A) polymorphisms are associated with microscopy-positive tuberculosis. Scand J Immunol 2006;63: 136-41.
59. Tso HW, Ip WK, Chong WP, Tam CM, Chiang AKS, Lau YL. Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun 2005;6: 358-363.
60. Amim LH, Pacheco AG, Fonseca-Costa J, Loredo CS, Rabahi MF, Melo MH, Ribeiro FC, Mello FC, Oliveira MM, Lapa E Silva JR, Ottenhoff TH, Kritski AL, Santos AR. Role of IFN-gamma +874 T/A single nucleotide polymorphism in the tuberculosis outcome among Brazilians subjects. Mol Biol Rep 2007 Aug 8; [Epub ahead of print].
61. Moran A, Ma X, Reich RA, Graviss EA. No association between the 874T/A single nucleotide polymorphism in the IFN-gene and susceptibility to TB. Int J Tuberc Lung Dis 2007;11(1): 113-115.
62. Vidyarani M, Selvaraj P, Prabhu Anand S, Jawahar MS, Adhilakshmi AR, Narayanan PR. Interferon gamma (IFNã) & interleukin-4 (IL-4) gene variants & cytokine levels in pulmonary tuberculosis. Indian J Med Res 2006;124: 403-410.
63. Cooke GS, Campbell SJ, Sillah J, Gustafson P, Bah B, Sirugo G, Bennett S, McAdam KPWJ, Sow O, Lienhardt C, Hill AVS. Polymorphism within the Interferon-ã/Receptor complex is associated with pulmonary tuberculosis. Am J Respir Crit Care Med 2006;174: 339-343.
64. Sallakci N, Coskun M, Berber Z, Gurkan F, Kocamaz H, Uysal G, Bhuju S, Yavuzer U, Singh M, Yegin O. Interferon-ã gene +874T-A polymorphism is associated with tuberculosis and gamma interferon response. Tuberculosis 2007;87: 225-30.
65. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000;342: 1350-1358.
66. Niimi T, Sato S, Sugiura Y, Yoshinouchi T, Akita K, Maeda H, Achiva H, Ninomiya S, Akita Y, Suzuki M, Nishio M, Yoshikawa K, Morishita M, Shimizu S, Uede R. Transforming growth factor-beta gene polymorphism in sarcoidosis and tuberculosis patients. Int J Tuberc Lung Dis 2002;6(6): 510-5.
67. Fiorenza G, Rateni L, Farroni MA, Bogue C, Dlugovitzky DG. TNF-alpha, TGF-beta and NO relationship in sera from tuberculosis (TB) patients of different severity. Immunol Lett 2005;98: 45-8.
68. Hajeer AH, Hutchison IV. Influence of TNF Ü gene polymorphisms on TNF production and diseases. Hum Immunol 2001;62: 1191-9.
69. Allen RD. Polymorphisms of the human TNF-alpha promoter - random variation or functional diversity? Mol Immunol 1999;36: 1017-27.
70. Vejbaesya S, Chierakul N, Luangtrakool P, Sermduangprateep C. NRAMP1 and TNF-a polymorphisms and susceptibility to tuberculosis in Thais. Respirology 2007;12: 202-206.
71. Goldfeld AE, Delgado JC, Thim S, Bozon MV, Uglialoro AM, Turbay D, Cohen C, Yunis EJ. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 1998;279(3): 226-8.
72. Selvaraj P, Sriram U, Mathan Kurian S, Reetha AM, Narayanan PR. Tumor necrosis factor aqlpha (-238 and -308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, -B and DR genes. Tuberculosis 2001;81: 335-41.
73. Bikmaeva AR, Sibiriak SV, Valiakhmetova DKh, Khusnutdinova EK. Polymorphism of the tumor necrosis alpha gene in patients with infiltrative tuberculosis and from the Bashkorstan populations. Mol Biol 2002;36(5): 784-7.
74. Scola L, Crivello A, Marino V, Gioia V, Serauto A, Candore G, Coloona-Romano G, Caruso C, Lio D. IL-10 and TNF-alpha polymorphism in a sample of Sicilian patients affected by tuberculosis: implication for ageing and life span expectancy. Mech Ageing Dev 2003; 124(4): 569-72.
75. Biedermann T, Zimmermann S, Himmelrich H, Gumv A, Egeter O, Sakrauski AK, et al. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat Immunol 2001;2: 1054-60.
76. Bogdan C, Vodovotz Y, Paik J, Xie QW, Nathan C. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J Leukoc Biol 1994;55: 227-33.
77. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3: 23-35.
78. Dabbagh K, Takeyama K, Lee HM, Ufki IF, Lausier JA, Nadel JA. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol 1999;162: 6233-37.
79. Doull IJ, Lawrence S, Watson M, Begishvili T, Beasley RW, Lampe F, Holgate T, Morton NE. Allelic association of gene markers on chromosome 5q and 11q with atopy and bronchial hyperresponsiveness. Am J Respir Crit Care Med 1996;153: 1280-4.
80. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, Borish L. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995;25(Suppl 2): 74-8.
81. Luoni G, Verra F, Arca B, Sirima BS, Troye-Blomberg M, Coluzzi M, Kwiatkowski D, Modiano D. Antimalarialantibody levels and IL-4 polymorphism in the Fulani of West Africa. Genes Immun 2001; 2: 411-4.
82. Saunders BM, Frank AA, Orme IM, Cooper AM. Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect Immun 2000;68 (6): 3322-6.
83. Ladel CH, Blum C, Dreher A, Reifenberg K, Kopf M, Kaufmann SH. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun 1997;65(11): 4843-9.
84. Giacomini E, Iona E, Ferroni L, Miettinen M, Fattorini L, Orefici G, Julkunen I, Coccia EM. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol 2001; 166(12):7033-41.
85. Murray PJ, Young RA. Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect Immun 1999;67: 3087-95.
86. Gong JH, Zhang M, Modlin RL, et al. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun 1996;64: 913-8.
87. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549-55.
88. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19: 683-765.
89. Fortsch D, Rollinghoff M, Stenger S. IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J Immunol 2000; 165: 978-987.
90. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnot PJ, Hutchinson IV. An investigation of polymorphism in the IL-10 gene promoter. Eur J Immunogen 1997;24: 1-8.
91. Turner J, Gonzalez-Juarrero M, Ellis DL, Basaraba RJ, Kipnis A, Orme IM, Cooper AM. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol 2002;169(11): 6343-6351.
92. Lopez-Maderuelo D, Arnalich F, Serantes R, Gonzalez A, Codoceo R, Madero R, Vazquez JJ, Montiel C. Interferongamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 2003;167(7): 970-975.
93. Oral HB, Budak F, Uzaslan EK, Basturk B, Bekar A, Akalin H, Ege E, Ener B, Goral G. Interleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis. Cytokine 2006;35: 143-147.
94. Shin HD, Park BL, Kim LH, Cheong HS, Lee IH, Park SK. Common interleukin 10 polymorphism associated with decreased risk of tuberculosis. Exp Mol Med 2005;37(2): 128-132.